iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
157.72
-0.71 (-0.45%)
At close: Nov 7, 2025, 4:00 PM EST
157.75
+0.03 (0.02%)
After-hours: Nov 7, 2025, 7:28 PM EST
IBB Holdings Information
IBB is an equity ETF with a total of 252 individual holdings. The top holdings are Amgen stock at 7.69%, Gilead Sciences at 7.66%, Vertex Pharmaceuticals at 7.46%, Regeneron Pharmaceuticals at 6.01%, and Alnylam Pharmaceuticals at 5.03%.
Total Holdings
25
Top 10 Percentage
48.97%
Asset Class
Equity
ETF Category
Health
Assets
6.72B
PE Ratio
19.75
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc. | 7.69% |
| 2 | GILD | Gilead Sciences, Inc. | 7.66% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.46% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.01% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.03% |
| 6 | INSM | Insmed Incorporated | 3.49% |
| 7 | ARGX | argenx SE | 3.33% |
| 8 | IQV | IQVIA Holdings Inc. | 3.23% |
| 9 | MTD | Mettler-Toledo International Inc. | 2.68% |
| 10 | NTRA | Natera, Inc. | 2.39% |
| 11 | BIIB | Biogen Inc. | 2.09% |
| 12 | WAT | Waters Corporation | 2.01% |
| 13 | ONC | BeOne Medicines AG | 1.88% |
| 14 | INCY | Incyte Corporation | 1.85% |
| 15 | UTHR | United Therapeutics Corporation | 1.81% |
| 16 | ILMN | Illumina, Inc. | 1.65% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.36% |
| 18 | MEDP | Medpace Holdings, Inc. | 1.22% |
| 19 | GMAB | Genmab A/S | 1.19% |
| 20 | IONS | Ionis Pharmaceuticals, Inc. | 1.07% |
| 21 | EXEL | Exelixis, Inc. | 0.97% |
| 22 | BBIO | BridgeBio Pharma, Inc. | 0.93% |
| 23 | RVMD | Revolution Medicines, Inc. | 0.90% |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.90% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 0.89% |
As of Nov 6, 2025